S930728J |
Xanthine oxidase inhibitor and related compounds |
Drugs, Metabolites |
Uric acid
Hypoxanthine
Xanthine
Oxipurinol
Allopurinol |
J'sphere ODS-M80 |
JM08S04-1546WT |
S930729B |
Xanthine oxidase inhibitor and related compounds |
Drugs, Metabolites |
Uric acid
Hypoxanthine
Xanthine
Oxipurinol
Allopurinol |
J'sphere ODS-L80 |
JL08S04-1546WT |
E211026A |
8-OHdG, an oxidative stress marker and related compounds |
Drugs, Metabolites |
7-Methylguanine (m7Gua)
8-Hydroxy-2’-deoxyguanosine (8-OHdG)
(-)-Nicotine
(-)-Cotinine
4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) |
YMC-Triart C18 |
TA12SP9-05Q1PT |
E211130A |
8-OHdG, an oxidative stress marker and related compounds |
Drugs, Metabolites |
4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL)
(-)-Cotinine
(-)-Nicotine
7-Methylguanine (m7Gua)
8-Hydroxy-2’-deoxyguanosine (8-OHdG) |
YMC-Triart Diol-HILIC |
TDH12SP9-10Q1PT |
F041213A |
Caffeine metabolites |
Drugs, Metabolites |
Caffeine(1,3-TMX)
Theophylline(1,3-DMX)
Paraxanthine(1,7-DMX)
Theobromine(3,7-DMX)
1-Methylxantine(1-MX)
1,7-Dimethyluric acid(1,7-DMU)
1,9-Dimethyluric acid(1,9-DMU) (l.S.)
5-Acetylamino-6-amino-3-methyluracil(AAMU)
1-methyluric acid(1-MU) |
YMC-Pack Polyamine II |
PB12S05-2546WT |
F041213B |
Caffeine metabolites in human urine |
Drugs, Metabolites |
Caffeine(1,3-TMX)
Theophylline(1,3-DMX)
Paraxanthine(1,7-DMX)
Theobromine(3,7-DMX)
1-Methylxantine(1-MX)
1,7-Dimethyluric acid(1,7-DMU)
1,9-Dimethyluric acid(1,9-DMU) (l.S.)
5-Acetylamino-6-amino-3-methyluracil(AAMU)
1-methyluric acid(1-MU) |
YMC-Pack Polyamine II |
PB12S05-2546WT |
G910607G |
Purine catabolites |
Drugs, Metabolites |
Allantoin
Allantoic acid
Uric acid |
YMC-Pack ODS-AM |
AM12S05-1506WT |
G910618A |
Purine catabolites |
Drugs, Metabolites |
Allantoin
Allantoic acid
Uric acid |
YMC-Pack ODS-AQ |
AQ12S05-1506WT |
H170712E |
Trimebutine |
Drugs, Metabolites Optical isomers |
Trimebtine |
CHIRAL ART Cellulose-SJ |
KSJ99S05-2546WT |
AA201208C |
Nafamostat mesilate (The Japanese Pharmacopoeia) |
Drugs, Metabolites |
Nafamostat mesilate
6-Amidino-2-naphthol hydrochloride |
YMC-Triart C18 |
TA12S05-2546PTH |
AA210326A |
Nafamostat and its metabolites |
Drugs, Metabolites |
p-Guanidinobenzoic acid hydrochloride
6-Amidino-2-naphthol hydrochloride
Nafamostat mesilate |
YMC-Triart C18 |
TA12SP9-05Q1PT |
U111102D |
Omeprazole(USP 34th;Assay) |
Drugs, Metabolites |
Omeprazole |
YMC-Triart C8 |
TO12S05-1546WT |
U111029A |
Omeprazole(JP 16th;Related substances) |
Drugs, Metabolites |
Omeprazole
1,2-Dinitrobenzene(I.S.) |
YMC-Triart C8 |
TO12S05-1546WT |
F150201J |
Omeprazole |
Drugs, Metabolites Optical isomers |
Omeprazole |
CHIRAL ART Amylose-SA |
KSA99S03-0503WT |
AB200830A |
Omeprazole(USP 34th;Assay) |
Drugs, Metabolites |
Esomeprazole magnesium
Omeplazole
Omeprazole sulfone |
YMC-Triart C8 |
TO12S05-1546PTH |
AB200829A |
Omeprazole(USP 34th;Assay) |
Drugs, Metabolites |
Esomeprazole magnesium
Omeplazole |
YMC-Triart C8 |
TO12S05-1546PTH |
U120322D |
Tacrolimus hydrate (JP 16th; Assay) |
Drugs, Metabolites |
Tacrolimus hydrate
Heptyl p-hydroxybenzoate(I.S.) |
YMC-Triart C18 |
TA12S05-1546WT |
U120413A |
Tacrolimus |
Drugs, Metabolites |
Tacrolimus |
YMC-Triart C18 |
TA12S03-1546WT |
U120413B |
Tacrolimus capsules |
Drugs, Metabolites |
Tacrolimus
Tacrolimus 19-epimer |
YMC-Triart C18 |
TA12S03-0546WT |
U120410C |
Tacrolimus capsules |
Drugs, Metabolites |
Tacrolimus |
YMC-Triart C18 |
TA12S03-1546WT |